Escolar Documentos
Profissional Documentos
Cultura Documentos
Critical limb ischemia (CLI) was rst dened in published form in 1982.1 The authors expressed intent was
that the term be only applied to patients without diabetes
From the Division of Vascular and Endovascular Surgery, Southern Arizona
Limb Salvage Alliance, University of Arizona Health Sciences Center,
Tucsona; the University of California San Francisco, San Franciscob; the
St. Elizabeths Medical Center, Brightonc; the University of Massachusetts Medical School, Worcesterd; the George Washington University
School of Medicine and Health Sciences, Washington, D.C.e; and the
Amputation Prevention Center, Valley Presbyterian Medical Center,
Van Nuys.f
Author conict of interest: none.
Additional material for this article may be found online at www.jvascsurg.org.
Reprint requests: Joseph L. Mills, Sr, MD, Division of Vascular and Endovascular Surgery, Southern Arizona Limb Salvage Alliance, University of
Arizona Health Sciences Center, Tucson, AZ 85724 (e-mail: jmills@u.
arizona.edu).
Independent peer-review and oversight has been provided by members of
the SVS Document Oversight Committee (Peter Gloviczki, MD (chair),
Thomas Forbes, MD, William D. Jordan Jr, MD, Glenn LaMuraglia,
MD, Michel Makaroun, MD, Greg Moneta, MD, Amy Reed, MD, Russell H. Samson MD, Timur Sarac, MD, and Thomas W. Wakeeld, MD).
0741-5214/$36.00
Copyright 2014 by the Society for Vascular Surgery.
http://dx.doi.org/10.1016/j.jvs.2013.08.003
220
Mills et al 221
222 Mills et al
Table I. Summary and comparison of existing diabetic foot ulcer, wound, and lower extremity ischemia classication
systems
Classication system
Ulcer
Gangrene
Rutherford8
Fontaine14
PEDIS43
No
No
UT34
No
Wagner35,36
No
No
Saint Elian39
No
IDSA42
No
No
Yes, wound/clinical
class 0-3
No
No
No
ABI, Ankle-brachial index; AP, ankle pressure; CLI, critical limb ischemia; DFUs, diabetic foot ulcers; IDSA, Infectious Disease Society of America; PAD,
peripheral artery disease; PEDIS, perfusion, extent/size, depth/tissue loss, infection, sensation; PVR, pulse volume recording; SAD, sepsis, arteriopathy,
denervation; SVS, Society for Vascular Surgery; TcPO2, transcutaneous oxygen pressure; TP, toe pressure; UT, University of Texas.
Mills et al 223
Table I. Continued.
Ischemia
Infection
No
No
Comments
Pure ischemia model PAD classication system
includes milder forms of PAD (categories 1-3);
Categories 4-6 based on cutoff values for CLI;
No spectrum of ischemia, does not
acknowledge potential need for
revascularization with <CLI cutoff depending
on wound extent/infection; Not intended for
patients with diabetes; Wound classes not
sufciently detailed; Omits infection as a trigger
Pure ischemia model; No clear denitions of
spectrum of hemodynamics; Minimal
description of wounds; Infection omitted
No
No
224 Mills et al
With respect to wound categorization, both the Fontaine14 and Rutherford8 classications of lower extremity
ischemia lack sufcient detail. DFU classications such as
perfusion, extent/size, depth/tissue loss, infection, sensation (PEDIS),43 University of Texas (UT),34 variants
of sepsis, arteriopathy, denervation (SAD),37,38,40,41 and
St Elian39 offer the benet of having been validated.
However, most DFU systems fail to provide sufcient
detail with regard to perfusion status and are ulcer systems,
with no specic mention of gangrene. Gangrene increases
risk of amputation compared with ulceration.44,45,56,58,61-65
Although the Wagner classication35,36 includes gangrene, it does not differentiate gangrene because of infection from that resulting from ischemia. It also fails to
characterize the degree of infection, ischemia, or wound
extent. Table I summarizes multiple existing classication
systems; strengths and limitations of each system are
noted in the comments column.
Mills et al 225
WOUND GRADES
INFECTION GRADES
ISCHEMIA GRADES
Ischemia in many DFU schemes is dened as an
ABI <0.8 and is considered as a simplied 6 variable
without gradations of severity. Multiple studies suggest
that patients with ABI >0.8 are at lower risk for amputation and unlikely to require revascularization to achieve
healing.34,44,54 In these patients, wound and infection
severity are the major determinants of amputation risk.
Patients with ABI >0.8 were therefore classied as
ischemia grade 0. At the other end of the perfusion
226 Mills et al
Table II. Society for Vascular Surgery Lower Extremity Threatened Limb (SVS WIfI) classication system
I. Wound
II. Ischemia
III. foot Infection
W I fI score
W: Wound/clinical category
SVS grades for rest pain and wounds/tissue loss (ulcers and gangrene):
0 (ischemic rest pain, ischemia grade 3; no ulcer) 1 (mild) 2 (moderate) 3 (severe)
Grade
Ulcer
Gangrene
0
No ulcer
Clinical description: ischemic rest pain (requires typical symptoms ischemia grade 3); no wound.
No gangrene
Grade
0
1
2
3
ABI
$0.80
0.6-0.79
0.4-0.59
#0.39
TP, TcPO2
>100 mm Hg
70-100 mm Hg
50-70 mm Hg
<50 mm Hg
$60 mm Hg
40-59 mm Hg
30-39 mm Hg
<30 mm Hg
ABI, Ankle-brachial index; PVR, pulse volume recording; SPP, skin perfusion pressure; TP, toe pressure; TcPO2, transcutaneous oximetry.
Patients with diabetes should have TP measurements. If arterial calcication precludes reliable ABI or TP measurements, ischemia should be documented by
TcPO2, SPP, or PVR. If TP and ABI measurements result in different grades, TP will be the primary determinant of ischemia grade.
Flat or minimally pulsatile forefoot PVR grade 3.
fI: foot Infection:
SVS grades 0 (none), 1 (mild), 2 (moderate), and 3 (severe: limb and/or life-threatening)
SVS adaptation of Infectious Diseases Society of America (IDSA) and International Working Group on the Diabetic Foot (IWGDF) perfusion, extent/size,
depth/tissue loss, infection, sensation (PEDIS) classications of diabetic foot infection
SVS
IDSA/PEDIS
infection severity
Uninfected
Mild
Mills et al 227
SVS
IDSA/PEDIS
infection severity
Moderate
Severea
PACO2, Partial pressure of arterial carbon dioxide; SIRS, systemic inammatory response syndrome.
a
Ischemia may complicate and increase the severity of any infection. Systemic infection may sometimes manifest with other clinical ndings, such as hypotension, confusion, vomiting, or evidence of metabolic disturbances, such as acidosis, severe hyperglycemia, new-onset azotemia.
From Lipsky et al.42
Table II. a, Key summary points for use of Society for Vascular Surgery Lower Extremity Threatened Limb (SVS WIfI)
classication system
1. Table II, the full system, is to be used for initial, baseline classication of all patients with ischemic rest pain or wounds within the
spectrum of chronic lower limb ischemia when reporting outcomes, regardless of form of therapy. The system is not to be employed for
patients with vasospastic and collagen vascular disease, vasculitis, Buergers disease, acute limb ischemia, or acute trauma (mangled
extremity).
2. Patients with and without diabetes mellitus should be differentiated into separate categories for subsequent outcomes analysis.
a. Presence of neuropathy (6) should be noted when possible in patients with diabetes in long-term studies of wound healing, ulcer
recurrence, and amputation, since the presence of neuropathy (loss of protective sensation and motor neuropathic deformity)
inuences recurrence rate.
3. In the Wound (W) classication, depth takes priority over size. Although we recommend that a wound, if present, be measured,
a shallow, 8-cm2 ulcer with no exposed tendon or bone would be classied as grade 1.
a. If a study of wound healing vs Wound (W) grade were performed, wounds would be classied by depth, and could also be
categorized by size: small (<5 cm2), medium (5-10 cm2), and large (>10 cm2)
4. TPs are preferred for classication of ischemia (I) in patients with diabetes mellitus, since ABI is often falsely elevated. TcPO2, SPP, and
at forefoot PVRs are also acceptable alternatives if TP is unavailable. All reports of outcomes with or without revascularization therapy
require measurement and classication of baseline perfusion.
5. In reporting the outcomes of revascularization procedures, patients should be restaged after control of infection, if present, and/or after
any debridement, if performed, prior to revascularization (Table IV).
a. Group a patients: no infection within 30 days, or simple infection controlled with antibiotics alone
b. Group b patients: had infection that required incision and drainage or debridement/partial amputation to control
ABI, Ankle-brachial index; PVR, pulse volume recording; SPP, skin perfusion pressure; TcPO2, transcutaneous oximetry; TP, toe pressure.
and those with wounds related to nonatherosclerotic conditions such as vasculitis, collagen vascular disease, Buergers
disease, neoplasm, dermatoses, and radiation.
The target population for this system includes any
patient with:
d
d
d
Ischemic rest pain, typically in the forefoot with conrmatory, objective hemodynamic studies (ABI <0.40,
AP <50, TP <30, TcPO2 <20)
A diabetic foot ulcer
Nonhealing lower limb or foot ulceration of at least
2 weeks duration
Gangrene involving any portion of the foot or lower
limb.
228 Mills et al
Mills et al 229
W-0
W-1
W-2
W-3
Ischemia 0
VL VL L
VL VL L
L
L
M
M M H
fI- fI- fI0
1
2
M
M
H
H
fI3
Ischemia 1
VL L M
VL L M
M M H
H
H H
fI- fI- fI0
1 2
Ischemia 2
L L M
L M H
M H H
H H H
fI- fI- fI0 1 2
H
H
H
H
fI3
H
H
H
H
fI3
Ischemia 3
L M M
M M H
H H H
H H H
fI- fI- fI0 1 2
H
H
H
H
fI3
W-0
W-1
W-2
W-3
Ischemia 0
VL VL VL
VL VL VL
VL VL VL
VL VL VL
f-0 fI- fI1
2
VL
VL
VL
VL
fI3
Ischemia 1
VL L L
L
M M
M M H
M M M
fI- fI- fI0
1 2
Ischemia 2
L L M
M H H
H H H
H H H
fI- fI- fI0 1 2
M
M
H
H
fI3
M
H
H
H
fI3
Ischemia 3
M H H
H H H
H H H
H H H
fI- fI- fI0 1 2
H
H
H
H
fI3
IDSA, Infectious Disease Society of America; PAD, peripheral artery disease; PEDIS, perfusion, extent/size, depth/tissue loss, infection, sensation; UT,
University of Texas.
to 48 possibilities. Quick perusal will note that many theoretically possible combinations are clinically unlikely, so the
actual number of probable scenarios is far more limited.
Most of the patients in the ischemia 1 and 2 blocks of 16
combinations suffer from situational ischemia. As wound
complexity and infection severity increase (a shift down and
to the right in each box of 16), the likelihood that revascularization will be required increases. In the ischemia 3 category, small wounds without infection may not always
require vascular intervention, but such an intervention
may speed healing. Again, shifts down and to the right
within this box increase the odds that vascular intervention
will be required; it likely will be mandatory for W 2 and
W 3 patients, especially in the presence of infection.
Since this is a new, updated system, we emphasize that
these consensus-based clinical stages will require rigorous
validation in large datasets that are generalizable to the
230 Mills et al
Table V. Wound, Ischemia, and foot Infection (WIfI) reclassication after debridement and control of infection (if
required)
The complete WIfI system is used to classify the patient at the time of initial presentation. In some patients with severe infection, the patient
might require urgent drainage and debridement prior to objective documentation of foot perfusion. In such cases, the initial ischemia
status would be listed as U (Unknown). The ischemia grade would be added after drainage of infection. If ischemia was detected and
measured, but urgent drainage of infection was nonetheless required, the patient must be reclassied after control of infection prior to
revascularization. This process could be simplied as follows:
Group a: No infection within 30 days or simple infection controlled with antibiotics alone
Group b: Infection controlled, but required incision and drainage, open toe or partial forefoot amputation
Wound
Wound
Wound
Wound
0
1
2
3
Ischemia 0
Ischemia 1
Ischemia 2
VL
VL
VL
VL
Ischemia 3
a
Mills et al 231
Proposed
clinical stages
Very low
Stage 1
Low
Stage 2
Moderate
Stage 3
High
Stage 4
I0 fI0,1
I1 fI0
I0 fI0,1
I1 fI 0
I0 fI2
I1 fI1
I2 fI0,1
I3 fI0
I0 fI2
I1 fI1
I2 0
I0 fI0/1
I0 fI3
I2 fI1,2
I3 fI1,2
I0 fI3
I1 fI2
I2 fI1
I3 fI0,1
I0 fI2
I 1 fI0,1
I2 0
I0 0,1
I1,2,3 fI3
I1 fI3
I2,3 fI2,3
I0 3
I1 fI2,3
I2 1,2,3
I3 fI0,1,2,3
I0 fI2,3
I1,2,3 fI0,1,2,3
of patients by clinical stage should yield a better platform for testing the impact of new therapies in
randomized trials.73 For example, trials targeting reduction
in amputation within 1 year as a primary end point of
a revascularization strategy might be focused on the
subjects who overlap clinical class 4 and moderate/high
anticipated benet for revascularization.
The WIfI classication system is not meant to function
as a stand-alone clinical decision-making tool. Patient risk
factors and comorbidities also play a major part in selecting
the best therapy. Existing proposed comorbidity indices
based on the Prevent III trial,27 the FinnVasc registry,63
the Eurodiale study,54,55 the BASIL trial,24-26 the Greenville LEGS score,62 and other sources need to be carefully
analyzed and resynthesized to create a comorbidity index
that could be used to guide appropriate therapy. Such
a comorbidity index could also be validated by utilizing
the strengths of the SVS Vascular Quality Initiative.72
Additionally, as we move forward, the need for a new
and simpler anatomic classication system that correlates
with outcomes after open bypass or endovascular therapy
will become increasingly clear. The scheme would need
232 Mills et al
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
Mills et al 233
66. Kalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome
of diabetic foot ulcers. Diab Care 1999;22:147-51.
67. DeGraaff JC, Ubbink DT, Legemate DA, Tijssen JGP, Jacobs MJHM.
Evaluation of toe pressures and transcutaneous oxygen measurements
in management of chronic critical leg ischemia: a diagnostic randomized clinical trial. J Vasc Surg 2003;38:528-34.
68. Castronuovo JJ, Adera HM, Smiell JM, Price RM. Skin perfusion
pressure measurement is valuable in the diagnosis of critical limb
ischemia. J Vasc Surg 1997;26:629-37.
69. Ballard JL, Eke CC, Bunt TJ, Killeen JD. A prospective evaluation
of transcutaneous oxygen measurements in the management of
diabetic foot problems. J Vasc Surg 1995;22:485-90; discussion:
490-2.
70. Braun JD, Trinidad-Hernandez M, Perry D, Armstrong DG, Mills JL.
Early quantitative evaluation of indocyanine green angiography in
patients with critical limb ischemia. J Vasc Surg 2013;57:1213-8.
71. McGraw KO, Wong SP. Forming inferences about some intraclass
correlation coefcients. Psychol Methods 1996;1:30-46.
72. Cronenwett JL, Likosky DS, Russell MT, Eldrup-Jorgensen J,
Stanley AC, Nolan BW, et al. A regional registry for quality assurance
and improvement: the Vascular Study Group of Northern New
England (VSGNNE). J Vasc Surg 2007;46:1093-101.
73. Subherwal S, Anstrom KJ, Jones WS, Felker MG, Misra S, Conte MS,
et al. Use of alternative methodologies for evaluation of composite end
points in trials of therapies for critical limb ischemia. Am Heart J
2012;164:277-84.
74. Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR,
Moneta GL, et al. Suggested objective performance goals and clinical
trial design for evaluating catheter-based treatment of critical limb
ischemia. J Vasc Surg 2009;50:1462-73.
75. Bertele V, Roncaglioni MC, Pangrazzi J, Terzian E, Tognoni G.
Clinical outcome and its predictors in 1560 patients with critical leg
ischaemia. Eur J Vasc Endovasc Surg 1999;18:401-10.
76. Chung J, Bartelson BB, Hiatt WR, Peyton BD, McLafferty RB,
Hopley CW, et al. Wound healing and functional outcomes after
infrainguinal bypass with reversed saphenous vein for critical limb
ischemia. J Vasc Surg 2006;43:1183-90.
77. AbouZamzam AM, Lee RW, Moneta GL, Taylor LM, Porter JM.
Functional outcome after infrainguinal bypass for limb salvage. J Vasc
Surg 1997;25:287-95.
78. Owens CD, Ho KJ, Kim S, Schanzer A, Lin J, Matros E, et al.
Renement of survival prediction in patients undergoing lower
extremity bypass surgery: stratication by chronic kidney disease classication. J Vasc Surg 2007;45:944-52.
79. Thorsen H, McKenna J, Tennant A, Holstein P. Nottingham health
prole scores predict the outcome and support aggressive revascularization for critical limb ischemia. Eur J Vasc Endovasc Surg 2002;23:
495-9.
80. Nguyen L, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL,
Belkin M, et al. Resource utilization in the treatment of critical limb
ischemia: the effect of tissue loss, comorbidities, and graft related
events. J Vasc Surg 2006;44:971-5.
81. Biancari F, Salenius JP, Heikkinen M, Luther M, Ylonen K,
Lepantalo M. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for
critical lower-limb ischemia: a Finnvasc registry study. World J Surg
2007;31:217-27.
82. Arvela E, Sderstrm M, Korhonen M, Halmesmki K, Albck A,
Lepntolo M, et al. Finnvasc score and modied Prevent III score
predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia. J Vasc Surg 2010;52:
1218-25.
83. Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS.
Risk stratication in critical limb ischemia: derivation and validation of
a model to predict amputation-free survival using multicenter surgical
outcomes data. J Vasc Surg 2008;48:1464-71.
84. Nicoloff AD, Taylor LM, McLafferty RB, Moneta GL, Porter JM.
Patient recovery after infrainguinal bypass grafting for limb salvage.
J Vasc Surg 1998;27:256-63.
234 Mills et al
85. Landry GJ. Functional outcome of critical limb ischemia. J Vasc Surg
2007;45:141A-8A.
86. Goodney PP, Likosky DS, Cronenwett JL. Predicting ambulation
status one year after lower extremity bypass. J Vasc Surg 2009;49:
1431-9.
87. Pomposelli FB Jr, Arora S, Gibbons GW, Frykberg R, Smakowski P,
Campbell DR, et al. Lower extremity arterial reconstruction in the
very elderly: successful outcome preserves not only the limb but also
residential status and ambulatory function. J Vasc Surg 1998;28:
215-25.
88. Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW,
Seely BL. Prospective multicenter study of quality of life before and
after lower extremity vein bypass in 1404 patients with critical limb
ischemia. J Vasc Surg 2006;44:977-83.
Submitted Aug 7, 2013; accepted Aug 13, 2013.
Supplementary Fig 1 (online only). Estimated 1-year amputation risk (%) by Society for Vascular Surgery (SVS) threatened limb
clinical stage.
Mills et al 234.e1
234.e2 Mills et al
Supplementary Fig 2 (online only). Clinical examples of Society for Vascular Surgery Lower Extremity Threatened
Limb (SVS WIfI) classication system. A, W 1 e shallow neuroischemic ulcer. B, W 1 e shallow neuroischemic mal
perforans ulcer over rst metatarsal head. C, W 2 e deep lateral ankle ulcer with exposed tendon. D, W 2 e deep ulcer
with exposed bone and tendon after debridement and control of infection. E, W 2 e digital gangrene (salvaged with
revascularization and great toe amputation). F, W 2 e forefoot wound classied after debridement and control of
infection. G, Successful transmetatarsal amputation after control of infection and tibial bypass (same patient as F). H,
W 3 e gangrene into midfoot, ultimately salvaged with dorsalis pedis bypass and modied transmetatarsal amputation.
I, W 3 e complex, deep, full-thickness heel ulcer. J, W 3 e complex heel ulcer, prior to debridement. K, W 3 e
intraoperative view during debridement (same patient as J). L, Clinical stage 5 e unsalvageable extremity, W 3, and fI 3
with systemic inammatory response syndrome.